全文获取类型
收费全文 | 129篇 |
免费 | 1篇 |
国内免费 | 1篇 |
专业分类
基础医学 | 12篇 |
口腔科学 | 1篇 |
临床医学 | 3篇 |
内科学 | 13篇 |
神经病学 | 29篇 |
外科学 | 46篇 |
预防医学 | 1篇 |
药学 | 19篇 |
肿瘤学 | 7篇 |
出版年
2022年 | 1篇 |
2021年 | 3篇 |
2017年 | 1篇 |
2015年 | 1篇 |
2013年 | 1篇 |
2012年 | 6篇 |
2011年 | 7篇 |
2010年 | 3篇 |
2009年 | 10篇 |
2008年 | 16篇 |
2007年 | 12篇 |
2006年 | 6篇 |
2005年 | 8篇 |
2004年 | 5篇 |
2003年 | 13篇 |
2002年 | 4篇 |
2001年 | 5篇 |
2000年 | 3篇 |
1999年 | 5篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1979年 | 1篇 |
1977年 | 2篇 |
1975年 | 1篇 |
排序方式: 共有131条查询结果,搜索用时 21 毫秒
1.
Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. 总被引:5,自引:0,他引:5
2.
3.
4.
Sakaguchi M Takao M Ohyama Y Oka H Yamashita H Fukuchi T Ashida K Murotani M Murotani M Majima K Morikawa H Hashimoto T Kiyota K Esaki H Amemoto K Isowa G Takao F 《World journal of gastroenterology : WJG》2012,18(13):1517-1524
AIM: To compare efficacy of proton pump inhibitors (PPIs) with H2-receptor antagonists (H2RAs) plus prokinetics (Proks) for dysmotility-like symptoms in functional dyspepsia (FD).METHODS: Subjects were randomized to receive open-label treatment with either rabeprazole 10 mg od (n = 57) or famotidine 10 mg bid plus mosapride 5 mg tid (n = 57) for 4 wk. The primary efficacy endpoint was change (%) from baseline in total dysmotility-like dyspepsia symptom score. The secondary efficacy endpoint was patient satisfaction with treatment.RESULTS: The improvement in dysmotility-like dyspepsia symptom score on day 28 was significantly greater in the rabeprazole group (22.5% ± 29.2% of baseline) than the famotidine + mosapride group (53.2% ± 58.6% of baseline, P < 0.0001). The superior benefit of rabeprazole treatment after 28 d was consistent regardless of Helicobacter pylori status. Significantly more subjects in the rabeprazole group were satisfied or very satisfied with treatment on day 28 than in the famotidine + mosapride group (87.7% vs 59.6%, P = 0.0012). Rabeprazole therapy was the only significant predictor of treatment response (P < 0.0001), defined as a total symptom score improvement ≥ 50%.CONCLUSION: PPI monotherapy improves dysmotility-like symptoms significantly better than H2RAs plus Proks, and should be the treatment of first choice for Japanese FD. 相似文献
5.
Horie N Hayashi K Morikawa M So G Takahata H Suyama K Nagata I 《Acta neurochirurgica》2011,153(5):1135-1139
Recently, endovascular management has been reported as a feasible option for Takayasu aortitis. However, few papers have focused
on restenosis in the follow-up, and therefore, it is important to predict high-risk cases for restenosis after endovascular
treatment. We herein report three cases with Takayasu aortitis showing repeated restenosis after endovascular percutaneous
transluminal angioplasty (PTA)/stenting and discuss its clinical implications with a review of the literature. We should keep
in mind that endovascular PTA/stenting for Takayasu aortitis does not always keep the patency of the affected vessels, and
severity of the stenosis and/or uncontrollable systemic inflammation could be a risk factor for restenosis. Therefore, careful
follow-up under strict control of inflammation is mandatory. Overall, this method is effective as an initial treatment since
repeated PTA is available until collateral supply develops. 相似文献
6.
7.
Suzuki T Uchida H Tanaka KF Nomura K Takano H Tanabe A Watanabe K Yagi G Kashima H 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2004,7(2):133-142
Antipsychotic polypharmacy has been empirically used and a recent trend in favour of that mode of therapy has been suggested for the treatment of schizophrenia. The clinical efficacy, however, still remains to be clarified. In order to critically evaluate the usefulness of such kind of psychopharmacotherapy, antipsychotic combination regimen (polypharmacy) was switched to a treatment with the single main antipsychotic (monotherapy) in cross-tapered fashion, while approximately maintaining the total amount, for patients with chronic schizophrenia. Patients had been treated with an average of three antipsychotics and maintained with the same antipsychotic polypharmacy regimen for more than 6 months before the entry. They were followed up with an antipsychotic monopharmacy and evaluated at 24 wk after completion of switching. Forty-seven patients were recruited for this study. Of 44 patients for whom evaluation was possible, 24 (54.5%) remained stable, while 10 (22.7%) showed improvement and the same number of patients ended in a deleterious status. Twenty-two patients were converted to antipsychotic monotherapy, while another 12 needed minimal dosing of low-potency agents. Overall, social functioning, evaluated by the Global Assessment of Functioning and the Clinical Global Impression, remained unchanged. Eighteen of 34 successful patients showed adverse effects of the main antipsychotic medication, which necessitated a significant dose reduction. Nine out of 10 deteriorating patients had been treated with a combination of low- and high-potency antipsychotics. It is suggested that many instances of antipsychotic polypharmacy is avoidable. The result is compatible with the current treatment recommendations, which dictate the use of a single antipsychotic agent. 相似文献
8.
Obata Y Li CJ Fujikawa M Takayama K Sato H Higashiyama K Isowa K Nagai T 《International journal of pharmaceutics》2001,212(2):223-231
The effect of 35 newly synthesized O-ethylmenthol (MET) derivatives on percutaneous absorption of ketoprofen was investigated in rats. In order to understand the relationship between the structure of compounds and promoting activity (structure-activity relationship), an artificial neural network (ANN) was employed. In the in vivo percutaneous absorption study, male Wistar rats, weighing 160-180 g, were used. The apparent penetration rate (Rp) was estimated based on a pharmacokinetic model with a constant rate of penetration through the skin after a lag time. As an index of the promoting activity of each compound, an enhancement factor (Ef), defined as follows, was used: Ef=Rp(with enhancer)/Rp(without enhancer). An irritation evoked on rat skin was microscopically judged at the end of the in vivo percutaneous absorption experiment and evaluated as a total irritation score (TIS). Ef and TIS were selected as output variables to determine the ANN structure. Calculated logP, molecular weight, steric energy (SE), van der Waals area, van der Waals volume, dipole moment, highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) were used as factors to determine the structural nature of cyclohexanol derivatives. Among these parameters, logP, SE and LUMO significantly affected the prediction of Ef and TIS. The predicted values of Ef and TIS coincided well with in vivo percutaneous absorption experimental values. However, results observed with a linear regression method were poor compared with the ANN approach. The contribution index of logP was approximately 50% in the prediction of Ef, suggesting that lipophilicity among physicochemical properties contributes most of the promoting activity of these compounds. 相似文献
9.
Clinical Variants of Tardive Dyskinesia in Japan 总被引:1,自引:1,他引:0
Toshiya Inada M.D. Gohei Yagi M.D. Kunitoshi Kaijima M.D. Kimio Ohnishi M.D. Mamoru Kamisada M.D. Robin W. Rockhold Ph.D. 《Psychiatry and clinical neurosciences》1991,45(1):67-71
Abstract: Involuntary movement disorders were investigated in a psychiatric hospital in Japan. The prevalence of tardive dyskinesia was 9.9 % and four clinical variants of tardive dyskinesia could be classified. Of the 716 patients, tardive dystonia was identified in 15 cases, tardive akathisia in one, respiratory dyskinesia in two and rabbit syndrome in 17. The existence of tardive forms for acute dystonic reactions and akathisia suggests that any type of acute extrapyramidal symptoms can have a tardive form. 相似文献
10.
Ryo Maeda Noritaka Isowa Hideyuki Onuma Hiroshi Miura Yuji Kawasaki Kazumichi Yamamoto 《General thoracic and cardiovascular surgery》2009,57(2):104-107
We report a rare case of biphasic pulmonary blastoma (BPB) with rapid progression in a 75-year-old man. Computed tomography
(CT) of the chest revealed a well-defined tumor shadow measuring 8 × 6 cm in the right upper lobe. CT-guided lung biopsy revealed
malignant cells with sarcomatous elements. Right upper lobectomy and systemic lymph node dissection with chest wall resection
were performed. Histopathologically, the tumor was composed of immature embryoniclike mesenchymal and epithelial components
that resembled embryonic lung tissue. The final diagnosis was BPB classified as pathological stage IIB (T3N0M0). Two months
later, the tumor recurred in the right supraclavicular lymph nodes. The patient died of respiratory failure due to tumor progression
7 months after surgery. 相似文献